Annual EBIT
-$24.48 M
+$9.02 M+26.92%
December 31, 2023
Summary
- As of February 7, 2025, CDTX annual earnings before interest & taxes is -$24.48 million, with the most recent change of +$9.02 million (+26.92%) on December 31, 2023.
- During the last 3 years, CDTX annual EBIT has risen by +$47.37 million (+65.92%).
- CDTX annual EBIT is now -2162.75% below its all-time high of -$1.08 million, reached on December 31, 2013.
Performance
CDTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$17.39 M
-$6.29 M-56.69%
September 30, 2024
Summary
- As of February 7, 2025, CDTX quarterly earnings before interest & taxes is -$17.39 million, with the most recent change of -$6.29 million (-56.69%) on September 30, 2024.
- Over the past year, CDTX quarterly EBIT has dropped by -$11.27 million (-184.03%).
- CDTX quarterly EBIT is now -216.56% below its all-time high of $14.92 million, reached on September 30, 2022.
Performance
CDTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$45.31 M
-$12.93 M-39.91%
September 30, 2024
Summary
- As of February 7, 2025, CDTX TTM earnings before interest & taxes is -$45.31 million, with the most recent change of -$12.93 million (-39.91%) on September 30, 2024.
- Over the past year, CDTX TTM EBIT has dropped by -$30.75 million (-211.22%).
- CDTX TTM EBIT is now -8005.55% below its all-time high of -$559.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CDTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.9% | -184.0% | -211.2% |
| 3 y3 years | +65.9% | -725.5% | -263.6% |
| 5 y5 years | +61.3% | -725.5% | -263.6% |
CDTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.1% | -216.6% | +4.8% | -643.3% | +31.5% |
| 5 y | 5-year | at high | +65.9% | -216.6% | +19.3% | -643.3% | +40.0% |
| alltime | all time | -2162.8% | +65.9% | -216.6% | +19.3% | -8005.6% | +40.0% |
Cidara Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.39 M(+56.7%) | -$45.31 M(+39.9%) |
| Jun 2024 | - | -$11.10 M(+3.8%) | -$32.38 M(+15.5%) |
| Mar 2024 | - | -$10.69 M(+74.6%) | -$28.03 M(+92.5%) |
| Dec 2023 | -$24.48 M(-26.9%) | -$6.12 M(+37.1%) | -$14.56 M(-42.9%) |
| Sep 2023 | - | -$4.47 M(-33.8%) | -$25.49 M(+318.1%) |
| Jun 2023 | - | -$6.75 M(-342.6%) | -$6.10 M(-51.1%) |
| Mar 2023 | - | $2.78 M(-116.3%) | -$12.46 M(-62.8%) |
| Dec 2022 | -$33.50 M(-20.7%) | -$17.05 M(-214.3%) | -$33.50 M(+0.8%) |
| Sep 2022 | - | $14.92 M(-213.8%) | -$33.22 M(-49.8%) |
| Jun 2022 | - | -$13.11 M(-28.2%) | -$66.18 M(+56.5%) |
| Mar 2022 | - | -$18.26 M(+8.9%) | -$42.29 M(+0.1%) |
| Dec 2021 | -$42.26 M(-41.2%) | -$16.77 M(-7.0%) | -$42.26 M(-10.2%) |
| Sep 2021 | - | -$18.04 M(-267.4%) | -$47.03 M(+1.1%) |
| Jun 2021 | - | $10.77 M(-159.1%) | -$46.53 M(-38.4%) |
| Mar 2021 | - | -$18.22 M(-15.4%) | -$75.51 M(+5.1%) |
| Dec 2020 | -$71.85 M(+72.2%) | -$21.55 M(+22.9%) | -$71.85 M(+11.6%) |
| Sep 2020 | - | -$17.53 M(-3.7%) | -$64.38 M(+46.9%) |
| Jun 2020 | - | -$18.21 M(+25.1%) | -$43.82 M(+9.9%) |
| Mar 2020 | - | -$14.56 M(+3.4%) | -$39.88 M(-4.4%) |
| Dec 2019 | -$41.72 M | -$14.08 M(-565.0%) | -$41.72 M(-5.7%) |
| Sep 2019 | - | $3.03 M(-121.2%) | -$44.24 M(-28.6%) |
| Jun 2019 | - | -$14.27 M(-13.0%) | -$61.99 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$16.40 M(-1.2%) | -$62.88 M(-0.6%) |
| Dec 2018 | -$63.28 M(+13.6%) | -$16.60 M(+12.7%) | -$63.28 M(+5.2%) |
| Sep 2018 | - | -$14.72 M(-2.8%) | -$60.15 M(+4.3%) |
| Jun 2018 | - | -$15.15 M(-9.9%) | -$57.67 M(-2.5%) |
| Mar 2018 | - | -$16.81 M(+24.9%) | -$59.13 M(+6.1%) |
| Dec 2017 | -$55.72 M(+15.0%) | -$13.46 M(+9.9%) | -$55.72 M(-1.6%) |
| Sep 2017 | - | -$12.25 M(-26.3%) | -$56.62 M(-0.2%) |
| Jun 2017 | - | -$16.61 M(+24.0%) | -$56.70 M(+9.1%) |
| Mar 2017 | - | -$13.40 M(-6.7%) | -$51.95 M(+7.3%) |
| Dec 2016 | -$48.44 M(+49.9%) | -$14.35 M(+16.4%) | -$48.44 M(+10.1%) |
| Sep 2016 | - | -$12.34 M(+4.0%) | -$44.01 M(+7.7%) |
| Jun 2016 | - | -$11.86 M(+20.0%) | -$40.88 M(+15.3%) |
| Mar 2016 | - | -$9.88 M(-0.4%) | -$35.47 M(+9.8%) |
| Dec 2015 | -$32.31 M(+222.6%) | -$9.93 M(+7.8%) | -$32.31 M(+19.5%) |
| Sep 2015 | - | -$9.21 M(+42.8%) | -$27.03 M(+27.8%) |
| Jun 2015 | - | -$6.45 M(-4.2%) | -$21.15 M(+30.6%) |
| Mar 2015 | - | -$6.73 M(+44.8%) | -$16.19 M(+61.6%) |
| Dec 2014 | -$10.02 M(+825.7%) | -$4.65 M(+40.0%) | -$10.02 M(+86.6%) |
| Sep 2014 | - | -$3.32 M(+123.1%) | -$5.37 M(+162.2%) |
| Jun 2014 | - | -$1.49 M(+166.2%) | -$2.05 M(+266.2%) |
| Mar 2014 | - | -$559.00 K | -$559.00 K |
| Dec 2013 | -$1.08 M | - | - |
FAQ
- What is Cidara Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cidara Therapeutics?
- What is Cidara Therapeutics annual EBIT year-on-year change?
- What is Cidara Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly EBIT year-on-year change?
- What is Cidara Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cidara Therapeutics?
- What is Cidara Therapeutics TTM EBIT year-on-year change?
What is Cidara Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CDTX is -$24.48 M
What is the all time high annual EBIT for Cidara Therapeutics?
Cidara Therapeutics all-time high annual earnings before interest & taxes is -$1.08 M
What is Cidara Therapeutics annual EBIT year-on-year change?
Over the past year, CDTX annual earnings before interest & taxes has changed by +$9.02 M (+26.92%)
What is Cidara Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CDTX is -$17.39 M
What is the all time high quarterly EBIT for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly earnings before interest & taxes is $14.92 M
What is Cidara Therapeutics quarterly EBIT year-on-year change?
Over the past year, CDTX quarterly earnings before interest & taxes has changed by -$11.27 M (-184.03%)
What is Cidara Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CDTX is -$45.31 M
What is the all time high TTM EBIT for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM earnings before interest & taxes is -$559.00 K
What is Cidara Therapeutics TTM EBIT year-on-year change?
Over the past year, CDTX TTM earnings before interest & taxes has changed by -$30.75 M (-211.22%)